MedicaidPrior AuthMedium impact
Palonosetron IV (Aloxi generics) (Revised)
Humana·SC · Oncology, Anesthesiology, General Surgery·Medicaid
Effective date
Nov 26, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicaid in South Carolina has established new prior authorization requirements for palonosetron IV (Aloxi generics), an anti-nausea medication used for chemotherapy-induced and postoperative nausea and vomiting. The policy sets specific age and indication criteria that must be met for approval.
Action Required
Before November 26, 2025: Billing team must update prior authorization procedures for palonosetron IV (Aloxi generics) for South Carolina Medicaid patients. Providers must obtain prior auth by documenting patient age, indication (chemotherapy-induced or postoperative nausea/vomiting), and meeting specific criteria outlined in the policy. Update encounter forms and EMR templates to capture required documentation. Claims without prior authorization will be denied.